Murine mucopolysaccharidosis type VII: The impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease
- 1 August 1998
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 21 (5) , 575-586
- https://doi.org/10.1023/a:1005423222927
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.Journal of Clinical Investigation, 1997
- Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII.Journal of Clinical Investigation, 1994
- Feline Mucopolysaccharidosis VII Due to β-glucuronidase DeficiencyVeterinary Pathology, 1994
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII.Journal of Clinical Investigation, 1994
- Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblastsNature Genetics, 1993
- Behavioural abnormalities in a murine model of a human lysosomal storage diseaseNeuroReport, 1993
- Arylsulfatase B-deficient mucopolysaccharidosis in rats.Journal of Clinical Investigation, 1993
- Herpesvirus vector gene transfer and expression of β–glucuronidase in the central nervous system of MRS VII miceNature Genetics, 1992
- N‐acetylglucosamine 6‐sulphatase deficiency in a Nubian goat: A model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID)Journal of Inherited Metabolic Disease, 1992
- Beta glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosisThe Journal of Pediatrics, 1973